|
TTF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.044000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.298400E-03 |
| Normal-vs-Stage2 |
2.588400E-01 |
| Normal-vs-Stage3 |
2.597000E-01 |
| Normal-vs-Stage4 |
4.420800E-01 |
| Stage1-vs-Stage2 |
4.242800E-01 |
| Stage1-vs-Stage3 |
7.52689999999889E-05 |
| Stage1-vs-Stage4 |
1.498730E-03 |
| Stage2-vs-Stage3 |
4.022000E-02 |
| Stage2-vs-Stage4 |
9.435700E-02 |
| Stage3-vs-Stage4 |
8.218400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.329600E-01 |
| Normal-vs-AfricanAmerican |
4.455800E-02 |
| Normal-vs-Asian |
5.038600E-01 |
| Caucasian-vs-AfricanAmerican |
7.382400E-02 |
| Caucasian-vs-Asian |
8.040000E-01 |
| AfricanAmerican-vs-Asian |
6.840600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.466800E-01 |
| Normal-vs-Female |
1.050300E-02 |
| Male-vs-Female |
5.243200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.432800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.551800E-02 |
| Normal-vs-Age(61-80Yrs) |
5.801200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.296400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.486400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.268600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.417000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.508990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.330800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.078000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.24900000003847E-06 |
| Normal-vs-Grade 2 |
5.383400E-04 |
| Normal-vs-Grade 3 |
4.917400E-01 |
| Normal-vs-Grade 4 |
6.201600E-02 |
| Grade 1-vs-Grade 2 |
1.210200E-02 |
| Grade 1-vs-Grade 3 |
1.55769999999888E-05 |
| Grade 1-vs-Grade 4 |
4.00270000000535E-06 |
| Grade 2-vs-Grade 3 |
5.24519999989259E-07 |
| Grade 2-vs-Grade 4 |
6.11279999951364E-07 |
| Grade 3-vs-Grade 4 |
1.284180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.07959999999341E-05 |
| Normal-vs-ccB subtype |
5.487800E-02 |
| ccA subtype-vs-ccB subtype |
2.88180590501952E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.548200E-01 |
| Normal-vs-N1 |
8.185800E-01 |
| N0-vs-N1 |
9.138600E-01 |
|
|
